Glifage XR
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Glifage XR, covering 2014-06-05 to 2014-06-05. Get the full timeline:
Most recent: Clinical Trial Update: BE Study of the Fixed Dose Combination of 5 mg Saxagliptin and 500 mg Metformin HCl XR Tablet Relative to a 5 mg Saxagliptin (Onglyza™) Tablet and a 500 mg Metformin HCl XR (Glifage® XR Marketed in Brazil by Merck S.A.) Tablet Co-Administered to Healthy Subjects in the Fasted and Fed States [Phase 1]